{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:02:03Z","timestamp":1746331323789,"version":"3.40.4"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,5,1]]},"DOI":"10.2169\/internalmedicine.4394-24","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T22:13:17Z","timestamp":1727388797000},"page":"1315-1320","source":"Crossref","is-referenced-by-count":0,"title":["Nasojejunal Tube Placement for Levodopa-carbidopa Intestinal Gel Treatment by Neurologists in Patients with Advanced Parkinson's Disease: A Retrospective Observational Study"],"prefix":"10.2169","volume":"64","author":[{"given":"Tatsuya","family":"Ueno","sequence":"first","affiliation":[{"name":"Department of Neurology, Aomori Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Haga","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aomori Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayasu","family":"Utsugisawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aomori Prefectural Central Hospital, Japan"},{"name":"Department of Neurology, Hirosaki University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiru","family":"Horiuchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aomori Prefectural Central Hospital, Japan"},{"name":"Department of Neurology, Hirosaki University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aomori Prefectural Central Hospital, Japan"},{"name":"Department of Neurology, Hirosaki University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iku","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aomori Prefectural Central Hospital, Japan"},{"name":"Department of Neurology, Hirosaki University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aomori Prefectural Central Hospital, Japan"},{"name":"Department of Neurology, Hirosaki University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aomori Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Tomiyama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hirosaki University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Chaudhuri KR, Kov\u00e1cs N, Pontieri FE, et al. Levodopa carbidopa intestinal gel in advanced Parkinson&apos;s disease: DUOGLOBE final 3-year results. J Parkinsons Dis 13: 769-783, 2023.","DOI":"10.3233\/JPD-225105"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Fasano A, Garc\u00eda-Ramos R, Gurevich T, et al. Levodopa-carbidopa intestinal gel in advanced Parkinson&apos;s disease: long-term results from COSMOS. J Neurol 270: 2765-2775, 2023.","DOI":"10.1007\/s00415-023-11615-3"},{"key":"3","unstructured":"3. National Institute for Health and Care Excellence. Parkinson&apos;s disease in adults (NG71) [Internet]. 2017 Jul 19 [cited 2024 Jul 11]. Available from: https:\/\/www.nice.org.uk\/guidance\/NG71"},{"key":"4","unstructured":"4. NHS England. Clinical commissioning policy: levodopa-carbidopa intestinal gel (LCIG). D04\/P\/e DuoDopa for Parkinsons disease [Internet]. Jul 2015 [cited 2024 Jul 11]. Available from: https:\/\/www.england.nhs.uk\/commissioning\/wp-content\/uploads\/sites\/12\/2015\/07\/d04-p-e.pdf"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Willows T, Dizdar N, Nyholm D, et al. Initiation of levodopa-carbidopa intestinal gel infusion using telemedicine (video communication system) facilitates efficient and well-accepted home titration in patients with advanced Parkinson&apos;s disease. J Parkinsons Dis 7: 719-728, 2017.","DOI":"10.3233\/JPD-161048"},{"key":"6","unstructured":"6. AbbVie. Summary of products characteristics for Duodopa<sup>\u00ae<\/sup> (UK) [Internet]. 2024 Oct 23 [cited 2024 Jul 11]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/6231\/smpc\/print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yamashita K, Yube Y, Yamazaki Y, et al. The impact of tube replacement timing during LCIG therapy on PEG-J associated adverse events: a retrospective multicenter observational study. BMC Neurol 21: 242, 2021.","DOI":"10.1186\/s12883-021-02269-7"},{"key":"8","unstructured":"8. Watanabe J, Ogawa Y, Okada Y, Mikami O. Long-term special drug use results study of Duodopa (3rd Interim report): real-world safety and effectiveness of levodopa-carbidopa intestinal gel. Bio Clin 37: 438-453, 2022 (in Japanese)."},{"key":"9","unstructured":"9. AbbVie<sup>\u00ae<\/sup> NJ Tube Instructions For Use (US) [Internet]. 2024 [cited 2024 Jul 11]. Available from: https:\/\/www.rxabbvie.com\/"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Antonini A, Stoessl AJ, Kleinman LS, et al. Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson&apos;s disease: a multi-country Delphi-panel approach. Curr Med Res Opin 34: 2063-2073, 2018.","DOI":"10.1080\/03007995.2018.1502165"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Schade S, Mollenhauer B, Trenkwalder C. Levodopa equivalent dose conversion factors: an updated proposal including opicapone and safinamide. Mov Dis Clin Pract 7: 343, 2020.","DOI":"10.1002\/mdc3.12921"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fujiwara Y, Suzuki H, Yasunaga M, et al. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr Gerontol Int 10: 225-232, 2010.","DOI":"10.1111\/j.1447-0594.2010.00585.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Goetz CG, Poewe W, Rascol O, et al. <i>Movement<\/i> Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations the <i>Movement<\/i> Disorder Society Task Force on rating scales for Parkinson&apos;s disease. Mov Dis 19: 1020-1028, 2004.","DOI":"10.1002\/mds.20213"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Goetz CG, Tilley BC, Shaftman SR, et al; the Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson&apos;s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23: 2129-2170, 2008.","DOI":"10.1002\/mds.22340"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Saranza G, Lang AE. Levodopa challenge test: indications, protocol, and guide. J Neurol 268: 3135-3143, 2021.","DOI":"10.1007\/s00415-020-09810-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gundert-Remy U, Hildebrandt R, Stiehl A, Weber E, Z\u00fcrcher G, Da Prada M. Intestinal absorption of levodopa in man. Eur J Clin Pharmacol 25: 69-72, 1983.","DOI":"10.1007\/BF00544017"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lennernas H, Nilsson D, Aquilonius S, Ahrenstedt O, Knutson L, Paalzow L. The effect of <sub>L<\/sub>-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man. Br J Clin Pharmacol 35: 243-250, 1993.","DOI":"10.1111\/j.1365-2125.1993.tb05691.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Amjad F, Bhatti D, Davis TL, et al. Current practices for outpatient initiation of levodopa-carbidopa intestinal gel for management of advanced Parkinson&apos;s disease in the United States. Adv Ther 36: 2233-2246, 2019.","DOI":"10.1007\/s12325-019-01014-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lew MF, Slevin JT, Kr\u00fcger R, et al. Initiation and dose optimization for levodopa-carbidopa intestinal gel: insights from phase 3 clinical trials. Parkinsonism relat disord 21: 742-748, 2015.","DOI":"10.1016\/j.parkreldis.2015.04.022"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Vijiaratnam N, Hewer S, Varley S, et al. Levodopa-carbidopa intestinal gel: is the naso-jejunal phase a redundant convention? Intern Med J 48: 469-471, 2018.","DOI":"10.1111\/imj.13754"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fasano A, Fung VSC, Lopiano L, et al. Characterizing advanced Parkinson&apos;s disease: OBSERVE-PD observational study results of 2615 patients. BMC Neurol 19: 50, 2019.","DOI":"10.1186\/s12883-019-1276-8"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/9\/64_4394-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:01:39Z","timestamp":1746244899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/9\/64_4394-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4394-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"article-number":"4394-24"}}